Latest filing published 29 Aug 2013 for Tobira Therapeutics, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Biodiscovery 3, FCPR: trading record in brief
Biodiscovery 3, FCPR is a declared insider of Tobira Therapeutics, Inc., with filings sourced from SEC (Form 4). In total, 3 filings cover trades dated 27 August 2013.
The open-market record is one-sided, with 1 purchase worth €3.6M and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The newest entry dates from 29 August 2013: a transaction, in Tobira Therapeutics, Inc. The clock since the last published purchase (29 August 2013) now reads 4,820 days. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Biodiscovery 3, FCPR
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,021,930 sharesCommon Stock, par value $0.001 per shareSEC:0001140361-13-034582:0
- 169,633 sharesCommon Stock, par value $0.001 per shareSEC:0001140361-13-034582:1
- 1,215,708 shares@ US$4.00Common Stock, par value $0.001 per shareSEC:0001140361-13-034582:2Canonical exit: 25 Nov 2013 (T+90)
3 of 3 declarations
